20/20 Biolabs prepares contingency plans for Ebola and Hantavirus testing

Go back to 20/20 Biolabs prepares contingency plans for Ebola and Hantavirus testing
(NASDAQ: AIDX) Delayed: 0.61 --0 (-0%)
Previous Close $0.61    52 Week High
Open $0.61    52 Week Low
Day High $0.61    P/E N/A 
Day Low $0.61    EPS
Volume 3,886